Business News

Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEO

FinSiddhi

Gland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to his acceptance of the offer. Sapra brings 27 years of executive experience, including over 23 years in pharmaceuticals, and currently leads API and Services at Dr Reddy’s Laboratories.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

Bank credit growth at two-year high at 18.6% as debt market turns costlier

Bank credit expanded significantly in the fortnight ending June 30. Deposit growth also showed a healthy increase during the same period. This credit demand stems from both consumer and corporate sectors. Corporate entities are increasingly favoring banks over debt markets for funding. The gap between credit and deposit growth widened to 570 basis points.

South Korean shares rebound from three-month low

South Korean shares saw a rebound on Wednesday after a significant previous day’s fall. Investors engaged in dip buying, focusing on domestic chipmaker earnings and major US tech firms. The benchmark KOSPI index experienced a notable increase, recovering from its lowest close in weeks. Chipmaker SK Hynix reported strong quarterly results, while Samsung Electronics also…